Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Celularity Inc (CELU)

Celularity Inc (CELU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 59,490
  • Shares Outstanding, K 19,378
  • Annual Sales, $ 17,980 K
  • Annual Income, $ 14,190 K
  • 60-Month Beta 0.30
  • Price/Sales 3.61
  • Price/Cash Flow 1.75
  • Price/Book 2.06
Trade CELU with:

Options Overview Details

View History
  • Implied Volatility 320.01% ( -48.25%)
  • Historical Volatility 88.51%
  • IV Percentile 45%
  • IV Rank 20.02%
  • IV High 1,289.74% on 08/17/23
  • IV Low 77.34% on 03/06/24
  • Put/Call Vol Ratio 99.00
  • Today's Volume 100
  • Volume Avg (30-Day) 50
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 2,614
  • Open Int (30-Day) 2,575

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.89 +4.32%
on 04/26/24
5.69 -46.92%
on 04/08/24
-2.01 (-39.96%)
since 03/26/24
3-Month
2.84 +6.26%
on 01/29/24
7.97 -62.11%
on 03/11/24
-0.41 (-12.03%)
since 01/26/24
52-Week
1.59 +89.94%
on 12/27/23
8.90 -66.07%
on 06/14/23
-3.33 (-52.46%)
since 04/26/23

Most Recent Stories

More News
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Celularity Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

CELU : 3.02 (-1.63%)
CELULARITY ANNOUNCES $45 MILLION PURCHASE ORDER, FIRST MIDDLE EAST PRIVATE LABEL AGREEMENT FOR CELULARITY'S HALAL-CERTIFIED BIOMATERIAL PRODUCTS

/PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial...

CELU : 3.02 (-1.63%)
HOOKIPA Pharma Inc. (HOOK) Reports Q1 Loss, Lags Revenue Estimates

HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of -12.50% and 15.31%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

HOOK : 0.8933 (+10.82%)
CELU : 3.02 (-1.63%)
Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Misses Revenue Estimates

Shattuck Labs, Inc. (STTK) delivered earnings and revenue surprises of 19.67% and 83.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

STTK : 10.59 (+8.28%)
CELU : 3.02 (-1.63%)
Akoya Biosciences (AKYA) Reports Q1 Loss, Tops Revenue Estimates

Akoya (AKYA) delivered earnings and revenue surprises of -6.52% and 5.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AKYA : 3.80 (-0.52%)
CELU : 3.02 (-1.63%)
Arvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue Estimates

Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -5.48% and 5.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ARVN : 32.37 (+2.44%)
CELU : 3.02 (-1.63%)
Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates

Blueprint Medicines (BPMC) delivered earnings and revenue surprises of 19.17% and 48.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BPMC : 93.00 (+2.50%)
CELU : 3.02 (-1.63%)
Biogen (BIIB) Beats on Q1 Earnings, Ends Some Research Programs

Biogen (BIIB) beats first-quarter estimates for earnings and sales. It maintains its 2023 guidance. Stock drops in pre-market trading.

BIIB : 208.90 (+3.18%)
RHHBY : 30.2500 (+0.77%)
ANVS : 18.01 (+32.43%)
CELU : 3.02 (-1.63%)
Assertio (ASRT) to Report Q1 Earnings: What's in the Cards?

On Assertio Therapeutics' (ASRT) Q1 earnings call, investors will likely focus on the sales performance of its rheumatology, pain and inflammation medicines.

RETA : 172.36 (+0.02%)
ASRT : 0.8282 (+5.49%)
AQST : 4.07 (+3.56%)
CELU : 3.02 (-1.63%)
Best Momentum Stocks to Buy for April 12th

CELU, PPG and LSCC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 12, 2023.

PPG : 130.16 (+0.72%)
LSCC : 73.88 (-0.04%)
CELU : 3.02 (-1.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Celularity Inc. is a clinical stage biotechnology company. It involved in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR and mesenchymal-like adherent stromal cells...

See More

Key Turning Points

3rd Resistance Point 3.75
2nd Resistance Point 3.56
1st Resistance Point 3.29
Last Price 3.02
1st Support Level 2.82
2nd Support Level 2.63
3rd Support Level 2.36

See More

52-Week High 8.90
Fibonacci 61.8% 6.11
Fibonacci 50% 5.24
Fibonacci 38.2% 4.38
Last Price 3.02
52-Week Low 1.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar